VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 179,283 shares of the real estate investment trust’s stock, valued at approximately $3,837,000.
A number of other institutional investors have also modified their holdings of the business. Advocate Investing Services LLC bought a new position in Healthpeak Properties in the fourth quarter worth about $26,000. Clearstead Trust LLC grew its holdings in shares of Healthpeak Properties by 66.7% during the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 543 shares during the last quarter. Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $31,000. Clearstead Advisors LLC raised its position in shares of Healthpeak Properties by 166.3% during the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after purchasing an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new stake in shares of Healthpeak Properties in the 2nd quarter worth approximately $33,000. Institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Price Performance
NYSE DOC opened at $20.41 on Thursday. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95. The firm has a market capitalization of $14.07 billion, a PE ratio of 58.32, a P/E/G ratio of 2.53 and a beta of 1.01. The company’s 50 day simple moving average is $21.48 and its 200 day simple moving average is $19.42. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02.
Healthpeak Properties Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.0%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s payout ratio is presently 348.57%.
Wall Street Analysts Forecast Growth
DOC has been the subject of a number of analyst reports. Scotiabank boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Morgan Stanley reiterated an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Citigroup boosted their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, August 11th. Cantor Fitzgerald upped their price target on shares of Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Four analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.72.
Get Our Latest Stock Analysis on DOC
Healthpeak Properties Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Further Reading
- Five stocks we like better than Healthpeak Properties
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
